Cargando…
Teicoplanin derivatives block spike protein mediated viral entry as pan-SARS-CoV-2 inhibitors
The rapid emergence of highly transmissible SARS-CoV-2 variants poses serious threat to the efficacy of vaccines and neutralizing antibodies. Thus, there is an urgent need to develop new and effective inhibitors against SARS-CoV-2 and future outbreaks. Here, we have identified a series of glycopepti...
Autores principales: | Ma, Ling, Li, Yali, Shi, Ting, Zhu, Zhiling, zhao, Jianyuan, Xie, Yongli, Wen, Jiajia, Guo, Saisai, Wang, Jing, Ding, Jiwei, Liang, Chen, Shan, Guangzhi, Li, Quanjie, Ge, Mei, Cen, Shan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Masson SAS.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9808420/ https://www.ncbi.nlm.nih.gov/pubmed/36916436 http://dx.doi.org/10.1016/j.biopha.2023.114213 |
Ejemplares similares
-
Repurposing of HIV/HCV protease inhibitors against SARS-CoV-2 3CL(pro)
por: Ma, Ling, et al.
Publicado: (2022) -
Identification of Darunavir Derivatives for Inhibition of SARS-CoV-2 3CL(pro)
por: Ma, Ling, et al.
Publicado: (2022) -
An Analogue of the Antibiotic Teicoplanin Prevents Flavivirus Entry In Vitro
por: De Burghgraeve, Tine, et al.
Publicado: (2012) -
SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis
por: Guo, Saisai, et al.
Publicado: (2022) -
The Zinc-Finger protein ZCCHC3 inhibits LINE-1 retrotransposition
por: Zhang, Zixiong, et al.
Publicado: (2022)